{
    "SPADE_UN_23803": {
        "Sequence Information": {
            "Peptide Name": "Hymenochirin-1B [P5K;E6,N10 S-Fmoc-ALA-4-pen]",
            "Sequence": "IKLSKXTKDXLKKVLKGAIKGAIAVAKMV",
            "Sequence Length": 29,
            "Biological Activity": [
                "Anticancer"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "W8PRC4",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/W8PRC4",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy.",
                    "Pubmed ID": "30789695",
                    "Reference": "ACS Chem Biol. 2019;14:516-525",
                    "Author": "Li Y, Zhang Y, Wu M, Chang Q, Hu H, Zhao X",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30789695"
                }
            ],
            "SPADE ID": "SPADE_UN_23803",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13416",
                    "Similarity": 1.0,
                    "Sequence": "IKLSKETKDNLKKVLKGAIKGAIAVAKMV"
                },
                {
                    "SPADE_ID": "SPADE_UN_13417",
                    "Similarity": 1.0,
                    "Sequence": "IKLSPKTKDNLKKVLKGAIKGAIAVAKMV"
                },
                {
                    "SPADE_ID": "SPADE_UN_13419",
                    "Similarity": 1.0,
                    "Sequence": "IKLSKKTKDNLKKVLKGAIKGAIAVAKMV"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Human lung carcinoma A549(IC50=2.26±0.24µM),Human colon adenocarcinoma HCT 116(IC50=2.95±0.25µM),Human hepatocellular carcinoma HepG2(IC50=2.20±0.27µM)"
        }
    }
}